Latest from NIDA

Opioids without the risk of addiction?

 |  Investigators have found that the opioid-galanin receptor heteromers determine the different effects of methadone as compared to morphine and fentanyl, showing methadone with a weaker ability to activate the dopaminergic...

The Genius of Chemogenetics

 |  Some NIDA-funded scientists have just published findings in the journal Science showing the development of a new, groundbreaking chemogenetics technology for modulating brain function in a remote, precise and ultra-sensitive...

The brain in pain

 |  NIDA-funded researchers identified a critical role for an internal brain opioid network called the dynorphin-kappa opioid receptor (KOR) system.

A whole new view of CB2

 |  NIDA-funded scientists have recently identified the crystal structure of the CB1 receptor and have some understanding of how it modulates the system.

New Insights for Astrocytes

 |  Scientists at NIDA's Intramural Research Program have just published a study suggesting that ventral midbrain astrocytes are physiologically distinct from astrocytes in other parts of the brain.